Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Krystal Biotech (KRYS) Gross Profit (2023 - 2025)

Historic Gross Profit for Krystal Biotech (KRYS) over the last 3 years, with Q3 2025 value amounting to $93.5 million.

  • Krystal Biotech's Gross Profit rose 2122.94% to $93.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $351.8 million, marking a year-over-year increase of 5731.17%. This contributed to the annual value of $270.5 million for FY2024, which is 46810.91% up from last year.
  • Latest data reveals that Krystal Biotech reported Gross Profit of $93.5 million as of Q3 2025, which was up 2122.94% from $88.9 million recorded in Q2 2025.
  • In the past 5 years, Krystal Biotech's Gross Profit ranged from a high of $93.5 million in Q3 2025 and a low of $8.3 million during Q3 2023
  • Moreover, its 3-year median value for Gross Profit was $77.2 million (2024), whereas its average is $64.9 million.
  • As far as peak fluctuations go, Krystal Biotech's Gross Profit skyrocketed by 82592.1% in 2024, and later surged by 2122.94% in 2025.
  • Krystal Biotech's Gross Profit (Quarter) stood at $39.3 million in 2023, then soared by 119.4% to $86.2 million in 2024, then grew by 8.55% to $93.5 million in 2025.
  • Its last three reported values are $93.5 million in Q3 2025, $88.9 million for Q2 2025, and $83.2 million during Q1 2025.